Biomedical Research Consortium for Regenerative Medicine Under Construction

A new US$126 million, 13,536-m2 biomedical research "collaboratory” will pursue joint projects by its members and collaboration partners to invent tools and technologies intended to advance research into stem cells, and to discover and develop innovative diagnostics and therapies.

The Sanford Consortium for Regenerative Medicine, a consortium of four world leaders in life sciences research (the Salk Institute for Biological Studies, The Scripps Research Institute (La Jolla, CA, USA), Sanford-Burnham Medical Research Institute (La Jolla), and the University of California, San Diego, hosted an official groundbreaking ceremony on March 26, 2010, in La Jolla, CA, USA.

The consortium, formed in 2006 to build and operate the biomedical research laboratory, consists of these four leading medical institutions--all internationally known for their exceptional contributions to medical research and treatments.

The Sanford Consortium for Regenerative Medicine will be a preeminent research center to develop the next generation of breakthrough cures, therapies, diagnostics, research tools, and technologies in stem cell research. The consortium's key research focuses on stem cell growth and differentiation, neuroscience, cardiovascular biology, blood cell development, and vision science.

The Sanford Consortium for Regenerative Medicine is designed as one of the most forward-thinking laboratories, effectively fostering informal collaboration and communication among researchers in a synergistic environment. Shared two-story break rooms interconnect all levels and encourage interaction among researchers. Approximately 330 investigators and associated staff will occupy the open labs, offices, and specialized core labs. Conference facilities include a 150-seat auditorium, large divisible conference room and a café.

Related Links:
Sanford Consortium for Regenerative Medicine